Search results
Should You Hold Gilead Sciences (GILD)?
Insider Monkey via Yahoo Finance Canada· 5 hours agoParnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter. A copy of the...
Recent uptick might appease Gilead Sciences, Inc. (NASDAQ:GILD) institutional owners after losing...
Simply Wall St. via Yahoo Finance Canada· 5 days agoKey Insights Institutions' substantial holdings in Gilead Sciences implies that they have...
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance Canada· 6 days agoIn the latest trading session, Gilead Sciences (GILD) closed at $69.61, marking a -1.58% move from...
Cancer Rates Surge: Key Biotech Stocks Leading the Charge in Oncology Drug Development
Baystreet· 4 days agoThe biotech sector is actively addressing this need, with recent notable developments from several companies, including: Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), GSK plc (NYSE: GSK ...
Game-Changing HIV Shot Can’t Get to High-Risk Groups Fast Enough
Bloomberg· 4 days agoLenacapavir proved it's possible to prevent 100% of infections in women. Lisa Jarvis is a Bloomberg...
The Corporate Reputation of Canadian Pharma, 2023-2024 - 100 Patient Groups Present their Views -...
Financial Post· 4 days agoDUBLIN — “The Corporate Reputation of Pharma in 2023/2024 – The Patient Perspective – Canada Edition – The Views of 100 Canadian Patient Groups” report has been added to ResearchAndMarkets.com ...
A Tech Reckoning Is Coming, Financial Pro Says. It’s Time to Play Defense.
Barrons.com· 3 days agoSpecifically, Bahnsen points to specific stocks such as American Electric Power Gilead Sciences and...
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
Zacks via Yahoo Finance Canada· 4 days agoPerformance Image Source: Zacks Investment Research The Nasdaq Biotechnology Index has gained 2.93%...
